Table of Contents
- Definition and Background of Zollinger-Ellison Syndrome
- Pathophysiology of Zollinger-Ellison Syndrome
- Epidemiology of Zollinger-Ellison Syndrome
- Presentation of Zollinger-Ellison Syndrome
- Differential Diagnosis of Zollinger-Ellison Syndrome
- Diagnosis of Zollinger-Ellison Syndrome
- Management of Zollinger-Ellison Syndrome
- Review Questions
Definition and Background of Zollinger-Ellison Syndrome
Zollinger-Ellison syndrome results from a pancreatic tumor in the non-beta islet cells, which stimulates the maximal activity of the gastric acid-secreting cells, resulting in gastrointestinal ulceration of the mucosa. Multiple endocrine neoplasia type 1 (MEN 1) is a familial autosomal dominant syndrome that includes Zollinger-Ellison syndrome as part of it; however, Zollinger-Ellison syndrome may still occur sporadically.
Pathophysiology of Zollinger-Ellison Syndrome
In Zollinger-Ellison syndrome, there is hypertrophy of the stomach mucosa caused by hypergastrinemia, which increases the numbers of the parietal cells and the maximal output of acid. Acid secretion is also stimulated by gastrin leading to increased secretion of basal acid. Different complications may result from the increased acid such as ulceration of the gastrointestinal mucosa, malabsorption and diarrhea.
Epidemiology of Zollinger-Ellison Syndrome
Spread of the Zollinger-Ellison syndrome in the United States
About 0.1 % to 1 % of patients suffering from duodenal ulcers in the United States have Zollinger-Ellison syndrome. And it is reported to have a similar frequency as insulinoma.
Spread of the Zollinger-Ellison syndrome international
The incidence differs from country to another, for example in Ireland it is reported as 0.5 cases per million patients per year. In Sweden the incidence is higher up to 1–3 cases per million patients per year.
Dependence of the Zollinger-Ellison syndrome on gender, age and race
There is no difference between races, and it appears that all races may be affected. Males have a slightly higher risk of developing the syndrome with a 1.3:1 male to female ratio. Zollinger-Ellison syndrome rarely appears in very young or old ages, with mean age of onset of 43 years.
Presentation of Zollinger-Ellison Syndrome
The diagnosis of Zollinger-Ellison syndrome needs good history, physical examination, and a high index of clinical awareness. Main symptoms include:
- Abdominal pain: It is the most common symptom presenting in more than 75 % of the patients. The abdominal pain is usually located in upper abdominal region and resembles the pain felt in peptic ulcer disease.
- Diarrhea: It is a common symptom too, with approximately 73 % of the patients reporting it. In women, diarrhea is more common as a symptom than abdominal pain. It is also more common in patients suffering from Multiple endocrine neoplasia type 1 than sporadic cases of Zollinger-Ellison syndrome.
- Heartburn: It resembles the pain of gastroesophageal reflux disease.
Other less common symptoms include:
- Gastrointestinal bleeding
- Weight loss
Physical examination may be normal and not reveal any signs or findings. However, signs may be present and they include:
- Epigastric tenderness
- Jaundice, if there is a compression over the common bile duct from the tumor
- Paleness due to the gastrointestinal bleeding
- Dental erosions
- Hepatomegally, which suggests metastasis to the liver
Differential Diagnosis of Zollinger-Ellison Syndrome
Clinical pictures similar to Zollinger-Ellison syndrome
- Retained gastric antrum syndrome
- Antral G-cell hyperplasia
- Gastric outlet obstruction
Diagnosis of Zollinger-Ellison Syndrome
- Fasting serum gastrin: This is the best screening test for Zollinger-Ellison syndrome. Serial measurements of fasting serum gastrin should be performed on different days because of the fluctuation that happens to the gastrin levels from day to day.
- Gastric acid secretary tests: Zollinger-Ellison syndrome is suspected if the basal acid output is greater than 15 mEq/h. Zollinger-Ellison syndrome is also suggested in the case of a large gastric volume and a gastric pH less than 2.0.
- Serum calcium levels: MEN type 1 is suspected in cases with high serum levels of calcium.
- Computed tomography scanning (CT): Even though CT is not highly sensitive for the localization of the primary tumor (it has 50 % sensitivity), it can still be used to localize some tumors especially if the tumor was bigger than 1 cm and to evaluate for metastatic disease.
- Somatostatin receptor scintigraphy: It is the imaging study of choice for the detection of Zollinger-Ellison syndrome and it is the most sensitive imaging modality for the detection of both primary and metastatic tumors.
- Endoscopic ultrasonography: It is still a new method used to localize gastrinomas.
- Abdominal ultrasound and magnetic resonance images can also be used; however, they have lower sensitivity than somatostatin receptor scintigraphy and CT scans.
- Esophagogastroduodenoscopy: This procedure is used to look for gastric folds hypertrophy and duodenal ulcerations.
Management of Zollinger-Ellison Syndrome
Surgical treatment of the tumor is the main therapy. However, medical treatment is used first to control the gastric acid hypersecretion; once it is controlled, imaging studies should be used to determine the size and location of the tumor in order to resect it surgically.
Proton pump inhibitors are the main medications used in the control of the gastric acid hypersecretion. Histamin 2 receptor blockers can also be used; however proton pump inhibitors are superior. Interferon, octreotide and chemotherapy may be used in the management of patients with metastatic disease. Hepatic metastasis may be treated with liver transplantation.
The main treatment for the tumor in Zollinger-Ellison syndrome is surgical resection especially in patients with no surgical contraindications and no metastasis. Surgical resection decreases the risk of developing hepatic metastasis.
In cases of MEN type 1, surgical intervention rarely cures the condition; however the risk of metastatic disease is decreased.
Follow up with secretin test, serum fasting gastrin levels, and somatostatin receptor scintigraphy after surgical resection is mandatory in order to make sure there is no recurrence. Follow up evaluation should be done every year with the first one being after 3 to 6 months from the surgical resection.
Proton pump inhibitors may be continued after surgical resection.
The correct answers can be found below the references.
1. A 43-year-old woman presents to your office complaining of abdominal pain between meals and frequent diarrhea. You perform endoscopy, and a duodenal ulcer distal to the duodenal bulb is revealed. A pancreatic mass is demonstrated by CT scan and a malignant islet cell tumor is revealed following a subsequent pancreatic tissue biopsy. What hormone would you expect to be highly elevated in this woman?
- Vasoactive intestinal peptide
2. A 46-year-old man presents to the emergency department because of severe sudden upper abdominal pain. Physical examination revealed that he is febrile, tachycardic and hypotensive. He has history of chronic lower back pain and recurrent nephrolithiasis. Emergency exploratory laporotomy is performed and a perforated gastric ulcer was revealed. The patient dies despite the appropriate management. Multiple ulcers in the duodenum, jejunum, and stomach were revealed later by autopsy. During the last few months he has been complaining of diarrhea and abdominal pain; however he was not taking any medications except for ibuprofen for his lower back pain during the past three weeks. Which of the following is the most likely cause for the presentation of this man?
- Cytomegalovirus infection
- Chronic NSAID use
- Gastrin-secreting tumor of the pancreas
- Infection with H. pylori
- Pancreatic tumor secreting vasoactive intestinal peptide
3. A 53-year-old male patient presented to your office complaining of persistent epigastric pain, which is preventing him from eating normally and caused him to loose 15 pounds over the last month. His past history includes a pituitary tumor status post trans-sphenoidal resection and parathyroid neoplasia. By physical examination you find that there is tenderness over the epigastric region. What would you expect depending on additional diagnostic tests?
- Elevated levels of gastrin and decreased levels of fasting serum gastrin after administration of secretin
- Normal levels of gastrin and normal levels of fasting serum gastrin after administration of secretin
- Elevated levels of gastrin and elevated levels of fasting serum gastrin after administration of secretin
- Decreased levels of gastrin and decreased levels of fasting serum gastrin after administration of secretin
- Decreased levels of gastrin and elevated levels of fasting serum gastrin after administration of secretin